Humane Genomics

A platform to make artificial viruses as cancer therapeutics.

Y CombinatorSummer 2021ActiveHealthcareTherapeuticsHard TechSynthetic Biology

What they do

Problem

Current cancer treatments often lack tumor-specific killing, leading to limited efficacy and harmful off-target toxicity.

Solution

A platform that engineers highly lytic RNA oncolytic viruses with dual safeguards for selective infection and replication to kill cancer cells.

Who it's for

Pediatric oncology clinicians and hospital cancer centers developing and administering oncolytic viral therapies.

Founders

Peter Weijmarshausen

Founder

Building a highly efficient platform to make artificial viruses as cancer therapeutics. Serial entrepreneur. Founder and former CEO of Shapeways. Have built and led software and product teams for 3 companies. Love to code, grow plants, brew beer, cook Asian food, and more. BSc Applied Physics.

LinkedIn · X

Chad Moles

Founder

Building a platform to engineer viruses as precision cancer therapies. Previous: Biotech, Columbia & Public Health, Tulane. Interested in sailing and pickleball.

LinkedIn · X